Literature DB >> 1737914

Uptake of organic anions by isolated rat hepatocytes. A classification in terms of ATP-dependency.

M Yamazaki1, H Suzuki, Y Sugiyama, T Iga, M Hanano.   

Abstract

Uptake of organic anions into isolated rat hepatocytes was studied to examine their ATP dependency. In the presence of rotenone (0.2 microM), the initial velocity of the uptake (Vo) of dibromosulfophthalein (DBSP; 10 microM), 1-anilino-8-naphthalenesulfonate (ANS; 10 microM) and benzylpenicillin (PCG; 0.02 microM) was reduced to 60-70% of the control value, while that of bromosulfophthalein (BSP; 10 microM), rose bengal (RB; 10 microM) and bromophenol blue (BPB; 10 microM) was not affected. Furthermore, we examined the inhibitory effect of rotenone on the uptake at equilibrium of non-metabolizable ligands (DBSP, BPB and RB). The uptake of these ligands reached equilibrium at 30 min with a cel-to-medium concentration ratio (C/M ratio) of 75, 37 and 126, respectively. The C/M ratio at equilibrium of DBSP was reduced by rotenone to approx. 60% of the control value, while that of BPB and RB was not reduced. Other metabolic inhibitors such as sodium azide (10 mM) and carbonylcyanide-p-trifluoromethoxyphenylhydrazone (FCCP; 10 microM) also reduced the Vo of DBSP and PCG, while the uptake of BSP and RB was not reduced by these inhibitors. These results indicate that organic anions can be classified into two groups according to whether they are taken up by hepatocytes in an ATP-dependent manner, i.e., via active transport or in an ATP-independent manner, i.e., via facilitated diffusion. DBSP, PCG and ANS belong to the former group, whereas BSP, BPB and RB belong to the latter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737914     DOI: 10.1016/0168-8278(92)90129-d

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Determination of the rate-limiting step in the hepatic elimination of YM796 by isolated rat hepatocytes.

Authors:  T Iwatsubo; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

2.  Hepatic disposition of fexofenadine: influence of the transport inhibitors erythromycin and dibromosulphothalein.

Authors:  R W Milne; L A Larsen; K L Jørgensen; J Bastlund; G R Stretch; A M Evans
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

Review 3.  Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.

Authors:  M Yamazaki; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

4.  Cellular uptake of fluvastatin, an inhibitor of HMG-CoA reductase, by rat cultured hepatocytes and human aortic endothelial cells.

Authors:  M Ohtawa; N Masuda; I Akasaka; A Nakashima; K Ochiai; M Moriyasu
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

5.  Quantitative drug interactions prediction system (Q-DIPS): a dynamic computer-based method to assist in the choice of clinically relevant in vivo studies.

Authors:  P Bonnabry; J Sievering; T Leemann; P Dayer
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

6.  Existence of two pathways for the endocytosis of epidermal growth factor by rat liver: phenylarsine oxide-sensitive and -insensitive pathways.

Authors:  Y Kato; H Sato; M Ichikawa; H Suzuki; Y Sawada; M Hanano; T Fuwa; Y Sugiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.